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In two centres urinary excretion ofHMMA was measured in a total of 359 children, aged from birth to 17 years, who were suspected of having a neuroblastoma; the diagnosis was subsequently confirmed in 39. Measurements were made on 24 h urine samples in 246 children, and on random samples in a further 113.
The urinary excretion of HMMA relative to creatinine declined progressively with increasing age. After the age of four years the rate of decline was such that some age groups could be combined for statistical analysis. The range of values for each group was similar whether 24 h or random urine collections were used. It is concluded that the latter are adequate for the initial assessment of HMMA excretion.
The measurement of 4-hydroxy-3-methoxy mandelic acid (HMMA) in urine is widely used to confirm the diagnosis of neuroblastoma. However, the interpretation of such measurements in children is difficult because excretion increases with age and varies widely between individuals of a given age and between the sexes. Relating the HMMA to creatinine excretion reduces the variation between individuals of the same agel and abolishes the sex difference.? but there remains a need for age-related reference ranges. The data so far published are, with a few exceptions (see Table  1 ), too sparse for age-related ranges to be determined under four years of age, or are not related to creatinine excretion.V
We have analysed the data from 359 children, inpatients and outpatients, in whom HMMA measurements were requested by the attending paediatrician because their illness suggested the possibility of neuroblastoma. We have also compared the value of random and 24 h urine collections for the measurement of HMMA excretion. Children without neuroblastoma in this group provide a more appropriate reference range for use in the diagnosis of neuroblastoma than normal children.
Patients and methods
Urine HMMA excretion was measured at clinical Correspondence: Dr G Walters, Department ofChemical Pathology, Bristol Royal Infirmary, Bristol BS2 8HW, UK. 44 presentation in a total of 359 children, aged from birth to 17 years, who were suspected at some stage of having a neuroblastoma. The studies were conducted in two centres, A and B. In 39 children, the diagnosis of neuroblastoma was subsequently confirmed; in the remaining 320 the diagnosis was eventually rejected and a neuroblastoma did not become evident during at least the next three years.
Measurements were made on 24 h urine samples in 145 children at centre A and 101 children at centre B; random urine samples were analysed in a further 113 children at centre B. None of these children was on a vanillin exclusion diet as this is now considered unnecessary. 7 In both centres the 24 h samples were collected into 20 mL of 5 M HCI, and the random samples were acidified with six drops of 12 M HCI within two hours of collection. HMMA was extracted and oxidised to vanillin by sodium periodate." Vanillin was estimated by spectrophotometry! in centre A and by gas liquid chromatography" in centre B.
The urinary creatinine was measured with the alkaline picrate method by a continuous flow autoanalyser.
STATISTICAL ANALYSIS
The differences in HMMA excretion between each age group were analysed statistically by the Mann-Whitney U test for the following comparisons: (1) 24 h urine collections at centre A versus 24 h urine collections at centre B; (2) random versus 24 h urine collections at centre B. Fig. 2 shows all the results from centre B alone, i.e. the 24 h values together with the first random sample to be analysed from each child; the 24 h collections and random samples were from different children. Inspection of the results for each year of age showed that the range declined progressively with increasing age until the age of four years. Thereafter the rate of decline was so slow that the age groups were combined in the manner shown in the illustrations. By this means the numbers in each group were maximised for statistical analysis. By the age of 12 years, adult values had been attained.
Figs. I and 2 show six values, numbered I to 6, which are very clearly separated from the remainder in their corresponding age groups.
They lie further from the next value down by more than one-third of the total range of values and are thus regarded as outliers." In addition there is another possible outlier in Fig. I, aged three years, and also one other in Fig. 2 in the 6 and 7 years old group. The final diagnoses in the numbered cases were: case I, disseminated intravascular coagulation; cases 2, 3 and 4, multiple inherited metabolic abnormalities associated with mental retardation and, in case 4, with spina bifida and hydrocephalus; case 5, bacterial meningitis; and case 6, transiently elevated blood pressure. HMMA excretion in the children numbered 1-5 subsequently returned to levels within the range of the majority of values; a repeat sample was not obtained from child 6 or from the other two possible outliers. Only one of the outliers was receiving drugs (phenobarbitone +Epilim); it is not known whether any drugs were taken by the other patients with raised values. . .
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x ' e '\( -, e '\( (P=0·03) and one year (P=0·02). For each age group the mean values obtained in centre A tended to be higher than those from centre B, a consistent difference that can be attributed to methodological differences."
The values obtained with random samples showed changes with age similar to the 24 h values. There were no statistically significant differences between the random and the 24 h values obtained by centre B (P> 0,05) .
In each age group and for both the 24 hand random urine collections the distribution of values is skewed and is not normalised by either logarithmic or square root transformation. In Figs. I and 2 the discontinuous lines, which have been drawn arbitrarily, indicate the limits which we regard as the upper limits of the reference ranges by the methods we used.
CASES OF NEUROBLASTOMA
There were 39 cases of neuroblastoma, 24 in centre A and 15 in centre B (Fig. 3) . The HMMA excretion in the first urine sample examined was elevated above the chosen reference range in 22 cases (56%). Of these, 16 (41%) had values greater than twice the upper limit of the reference values. The remaining 17 children (44%) did not have elevated values at presentation but 5 subsequently showed an increase within two weeks; 6 others in whom more than one sample was analysed never showed an increase in HMMA excretion. The lowest value at presentation of any neuroblastoma was 1·8 Jl.mol HMMA/mmol creatinine. Overall, the sensitivity was 56% and the specificity 96%.
Discussion
The skewed distribution of the data, even after logarithmic and square root transformations, renders inappropriate the expression of a reference range as the mean±2 SD. This stricture seems to be applicable also to the published ranges given in Table 1 , most of which extend below zero. The data in our separate age groups, and those in the table, are also too few for the satisfactory use of non-parametric methods." In these circumstances taking the range of values, after excluding outliers, is as useful as any other procedure. Accurate definition of the lower limits of the reference ranges is not important, as the occurrence of values as low as 1·8 Jl.mol VMA/ mmol creatinine in patients with a neuroblastoma indicates that there is no level of urinary HMMA which, practically, can be taken safely to exclude a neuroblastoma.
As 75% of neuroblastomas occur before the age of four years, the rapid fall during this period in the range of values for the ratio of HMMA to creatinine necessitates reference ranges at least on a yearly basis. It must be remembered that children aged 13 months wi1l, on average, have higher values than those aged 23 months, although they all fall within the same reference interval of one to two years. After the age of four years, combining the less numerous data from adjacent yearly groups seems acceptable for the purpose of establishing a reference range. Our ranges derived from 24 h urines are similar to those in Table 1 , with the exception of the early data from Gitlow et al.,' which is unexplained.
In babies and small children the use of random samples instead of 24 h collections would be much more convenient; according to Gitlow et al,' it is just as satisfactory, a view supported by others.v' Hanal et al:" have successfully used spots of urine collected onto filter paper for a neuroblastoma screening programme. In our series somewhat higher limits for the urinary HMMA/creatinine ratios have been set for random than for the 24 h collections (Fig. 2) , but the great majority of the random results do fall within the ranges set for the 24 h results obtained by "the same analytical method. There are some differences between our random results and those quoted in Table I , which persist even after allowing for methodological differences. Reasons for this cannot be evaluated as the data in Table 1from Haymond et al. J and Tuchman et al. 4 were not reported in detail, so that possible effects of a skewed distribution cannot be assessed. This applies also to an upper limit of 10 /lmol VMA/mmol creatinine for normal children aged 6-12 months, quoted by Hanal et al.;" even though they observed values as high as 50. Their data relate to a screening programme for neuroblastoma, and we presume that they have chosen a low value to minimise the number of false negatives.
The purpose of using the HMMA/creatinine ratio is to reduce differences between individuals of the same age due to variations in body size. With random samples the possibility of some variation in the ratio resulting from transient fluctuations in renal function cannot be excluded. This does not seem likely to be a problem in practice. The interpretation of values around the upper limit of the reference ranges requires caution, but no more than is required for the interpretation of values from 24 h collections. It seems, therefore, that the use of random urines for the initial investigations will, in most cases, be satisfactory. Borderline high results warrant the analysis of further specimens including one or more 24 h specimens, and also the measurement of urinary homovanillic acid.
In the absence of a neuroblastoma a raised value in an acutely ill child is not remarkable, but the explanation in the 3 cases with inherited metabolic abnormalities and mental retardation is not apparent. Increased excretion ofHMMA is known to occur under conditions of physical and emotional stress" but the importance of these factors in our cases cannot be assessed.
